Chronic inflammatory demyelinating polyneuropathy (CIDP) is such a remarkably heterogeneous disorder – one with diverse presentations, a highly variable disease course, and differing, often unpredictable treatment responses – that neurologist-researchers around the world have established research registries in recent years to prospectively study patients over time.